pX459V2.0-eSpCas9(1.1) Citations (9)
Originally described in: Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 with improved proof-reading enhances homology-directed repair.Kato-Inui T, Takahashi G, Hsu S, Miyaoka Y Nucleic Acids Res. 2018 May 18;46(9):4677-4688. doi: 10.1093/nar/gky264. PubMed Journal
Articles Citing pX459V2.0-eSpCas9(1.1)
| Articles |
|---|
| TBC1D8B Mutations Implicate RAB11-Dependent Vesicular Trafficking in the Pathogenesis of Nephrotic Syndrome. Kampf LL, Schneider R, Gerstner L, Thunauer R, Chen M, Helmstadter M, Amar A, Onuchic-Whitford AC, Loza Munarriz R, Berdeli A, Muller D, Schrezenmeier E, Budde K, Mane S, Laricchia KM, Rehm HL, MacArthur DG, Lifton RP, Walz G, Romer W, Bergmann C, Hildebrandt F, Hermle T. J Am Soc Nephrol. 2019 Dec;30(12):2338-2353. doi: 10.1681/ASN.2019040414. Epub 2019 Nov 15. PubMed |
| Application of CRISPR/Cas9 editing and digital droplet PCR in human iPSCs to generate novel knock-in reporter lines to visualize dopaminergic neurons. Uberbacher C, Obergasteiger J, Volta M, Venezia S, Muller S, Pesce I, Pizzi S, Lamonaca G, Picard A, Cattelan G, Malpeli G, Zoli M, Beccano-Kelly D, Flynn R, Wade-Martins R, Pramstaller PP, Hicks AA, Cowley SA, Corti C. Stem Cell Res. 2019 Dec;41:101656. doi: 10.1016/j.scr.2019.101656. Epub 2019 Nov 9. PubMed |
| Mitochondrial aconitase controls adipogenesis through mediation of cellular ATP production. Chen Y, Cai GH, Xia B, Wang X, Zhang CC, Xie BC, Shi XC, Liu H, Lu JF, Zhang RX, Zhu MQ, Liu M, Yang SZ, Yang Zhang D, Chu XY, Khan R, Wang YL, Wu JW. FASEB J. 2020 May;34(5):6688-6702. doi: 10.1096/fj.201903224RR. Epub 2020 Mar 24. PubMed |
| A simple, quick, and efficient CRISPR/Cas9 genome editing method for human induced pluripotent stem cells. Geng BC, Choi KH, Wang SZ, Chen P, Pan XD, Dong NG, Ko JK, Zhu H. Acta Pharmacol Sin. 2020 Jun 18. pii: 10.1038/s41401-020-0452-0. doi: 10.1038/s41401-020-0452-0. PubMed |
| Longitudinal Imaging of Liver Cancer Using MicroCT and Nanoparticle Contrast Agents in CRISPR/Cas9-Induced Liver Cancer Mouse Model. An SB, Yang K, Kim CW, Choi SH, Kim E, Kim SD, Koh JS. Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211016466. doi: 10.1177/15330338211016466. PubMed |
| A cleavage-based surrogate reporter for the evaluation of CRISPR-Cas9 cleavage efficiency. Jung SB, Lee CY, Lee KH, Heo K, Choi SH. Nucleic Acids Res. 2021 Sep 7;49(15):e85. doi: 10.1093/nar/gkab467. PubMed |
| UCHL1 protects against ischemic heart injury via activating HIF-1alpha signal pathway. Geng B, Wang X, Park KH, Lee KE, Kim J, Chen P, Zhou X, Tan T, Yang C, Zou X, Janssen PM, Cao L, Ye L, Wang X, Cai C, Zhu H. Redox Biol. 2022 Jun;52:102295. doi: 10.1016/j.redox.2022.102295. Epub 2022 Mar 18. PubMed |
| CLPTM1L is a GPI-anchoring pathway component targeted by HCMV. Kol I, Rishiq A, Cohen M, Kahlon S, Pick O, Dassa L, Stein N, Bar-On Y, Wolf DG, Seidel E, Mandelboim O. J Cell Biol. 2023 Sep 4;222(9):e202207104. doi: 10.1083/jcb.202207104. Epub 2023 Jun 30. PubMed |
| Prime editing-mediated correction of the leptin receptor in muscle cells of db/db mice. Lee KE, Xu Y, Geng B, Kim J, Kellon N, He Z, Zhang Z, Li D, Gouchoe DA, Zhu H. Biotechnol J. 2024 May;19(5):e2300676. doi: 10.1002/biot.202300676. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.